SEC Form 4 · accession 0001179110-17-007104
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President · Director
Period of report
May 10, 2017
Accepted (ET)
May 12, 2017 · 2:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | May 10, 2017 | S | 1,852 | $15.77 | D | 283,977 | D | |
| Common StockF4 | holding | — | — | — | 277,477 | I | Craig Wheeler Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2016.
- F2This transaction was executed in multiple trades at prices ranging from $15.50 to $15.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3Reflects a decrease of 15,536 shares of MNTA common stock transferred to the Craig Wheeler Revocable Trust on March 2, 2017.
- F4Reflects the transfer of 15,536 shares of MNTA common stock on March 2, 2017 to the Craig Wheeler Revocable Trust that were previously held directly by Mr. Wheeler.